Reducing dietary saturated fatty acids (SFA) intake results in a clinically significant lowering
of low-density lipoprotein cholesterol (LDL-C) across ethnicities. In contrast, dietary SFA's …

Purpose This study reviewed the contribution of inflammation to atherosclerotic
cardiovascular disease (ASCVD), which has gained widespread recognition in recent years …

Abstract Background and aims The European Atherosclerosis Society (EAS) Lipid Clinics
Network promoted a survey in order to identify and understand how and when lipoprotein …

Cardiovascular diseases (CVDs) which consist of ischemic heart disease, stroke, heart
failure, peripheral arterial disease, and several other cardiac and vascular conditions are …

This study examined the associations between emerging lipid biomarkers (small dense low‐
density lipoprotein cholesterol [sdLDL‐C), lipoprotein (a)[Lp (a)], and free fatty acids [FFA]) …

Routine genetic testing in hypercholesterolemia patients reveals a causative monogenic
variant in less than 50% of affected individuals. Incomplete genetic characterization is partly …

Background and aims Lipoprotein (a)[Lp (a)] and interleuking-6 (IL-6), an inflammation
biomarker, have been established as distinct targets of the residual atherosclerotic …

Elevated lipoprotein (a) is an independent causal risk factor for atherosclerotic
cardiovascular disease and aortic valve stenosis and measuring lipoprotein (a) once in all …

Abstract Background and Aims Recent investigations have suggested an interdependence
of lipoprotein (a)[Lp (a)]-related risk for cardiovascular disease with background …

Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en
nuestro país. El control adecuado de las alteraciones del metabolismo lipídico es un reto …